ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia

Journal of Infection in Developing Countries

Volumn 8, Issue 9, 2014, Pages 1129-1136

  Somily, Ali Mohammed ^a   Habib, Hanan A ^a   Absar, Muhammad M ^a   Arshad, Muhammad Z ^a   Manneh, Kutubu ^a   Al Subaie, Sarah S ^a   Al Hedaithy, Mogbil A ^a   Sayyed, Samina B ^a   Shakoor, Zahid ^a   Murray, Thomas S ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b QUINNIPIAC UNIVERSITY   (United States)

Author keywords

Antibiotics; Escherichia coli; Extended spectrum beta lactamases; Klebsiella pneumoniae; Susceptibility

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD SAMPLING; CONTROLLED STUDY; EPSILOMETER TEST; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NOSE SMEAR; PROSPECTIVE STUDY; SAUDI ARABIA; TERTIARY CARE CENTER; URINALYSIS; ADOLESCENT; AGED; CHILD; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; INFANT; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SAUDI ARABIA; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84907014891     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4292     Document Type: Article

References (35)

1. Oberoi L, Singh N, Sharma P, Aggarwal A (2013) ESBL, MBL and Ampc β Lactamases Producing Superbugs - Havoc in the Intensive Care Units of Punjab India. J Clin Diagn Res 7: 70-73.
2. Paterson DL, Bonomo RA (2005) Extended-Spectrum β-Lactamases: a Clinical Update. Clin Microbiol Rev 18: 657-686.
3. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Oh MD, Choe KW (2004) Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-β-Lactamase-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother 48: 3720-3728.
4. Drawz SM, Bonomo RA (2010) Three Decades of β-Lactamase Inhibitors. Clin Microbiol Rev 23: 160-201.
5. Pitout JDD, Nordmann P, Laupland KB, Poire L (2005) Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
6. Pitout JDD, Gregson DB, Church DL, Elsayed S, and Laupl KB (2005) Community-Wide Outbreaks of Clonally Related CTX-M-14 β-Lactamase-Producing Escherichia coli Strains in the Calgary Health Region. J Clin Micro 43: 2844-2849.
7. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14: 933-951.
8. Kader AA, Kumar AK (2004) Frequency of extended spectrum beta-lactamase among multidrug resistant Gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J 25: 570-574.
9. Kader AA, Kumar AK (2005) Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other Gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J 26: 956-959.
10. Babay HA (2002) Detection of extended-spectrum β-lactamases in members of the family enterobacteriaceae at a teaching hospital, Riyadh, Kingdom of Saudi Arabia. Saudi Med J 23: 186-190.
11. El-Khizzi NA, Bakheshwain SM (2006) Frequency of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 27: 37-40.
12. Babini GS, Livermore DM (2000) Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 45: 183-189.
13. Jarlier V, Nicolas MH, Fournier G, Philippon A (1998) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta lactam agents in Enterobacteriaceae: hospital frequency and susceptibility patterns. Rev Infect Dis 10: 867-878.
14. Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. Document M100-S21, CLSI: Wayne, PA, USA.
15. Bonfiglio G, Perilli M, Stefani S, Amicosante G, Nicoletti G (2002) Frequency of extended spectrum β-lactamases among Enterobacteriaceae: an Italian survey. Int J Antimicrob Agents 19: 213-217.
16. Peirano G, van der Bij AK, Gregson DB, Pitout JD (2012) Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia colicausing bacteremia in a centralized Canadian region. J Clin Microbiol 50: 294-299.
17. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL (2009) Emergence of high levels of extended-spectrum-β-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007. Antimicrob Agents Chemother 53: 3280-3284.
18. Winokur PL, Canton R, Casellas JM, Legakis N (2001) Variations in the prevalence of strains expressing beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 15: 94-103.
19. Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA (2004) Determining incidence of extended-spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 24: 119-124.
20. Mokaddas EM, Abdulla AA, Shati S, Rotimi VO (2008) The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother 20: 445-451.
21. Bindayna KM, Senok AC, Jamsheer AE (2009) Frequency of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain. J Infect Public Health 2: 129-135.
22. Al-Zarouni, Senok A, Rashid F, Al-Jesmi, Panigrahi D (2008) Frequency and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 17: 32-36.
23. Health Protection Surveillance Centre Annual Report (2007) Available: http://www.hpsc.ie/hpsc/AboutHPSC/AnnualReports/File,3377,en.pdf AccessedSeptember 6, 2014
24. Fennell J, Vellinga A, Hanahoe B, Morris D, Boyle F, Higgins F, Lyons M, O'Connell K, Keady D, Cormican M (2012) Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study. BMC Infect Dis 12: 116.
25. Livermore DM, Hawkey PM (2005) CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56: 451-454.
26. Al-Agamy M, Shibl A, Tawfik A (2009) Frequency and molecular characterization of extended spectrum beta-lactamases-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 29: 253-257.
27. Kader AA, Kumar A (2005) Frequency and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 25: 239-242.
28. Haldorsen BC, Simonsen GS, Sundsfjord A, Samuelsen O (2014) Norwegian Study Group on Aminoglycoside Resistance. Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6')-Ib. Diagn Microbiol Infect Dis 78: 66-69.
29. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280: 1233-1237.
30. Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Cueto Md, Gálvez J, Perea EJ, Pascual A (2008) Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clin Microbiol Infect 14: 180-183.
31. Paterson DL (2006) Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 34: S20-28.
32. Hernandez MS, Garcia JA, Munoz JL (2009) In vitro activity of fosfomycin against ESBL-producing enterobacteriaceae of urinary origin. Rev Esp Quimioter 22: 25-29.
33. Mashouf RY, Babalhavaeji H, Yousef J (2009) Urinary tract infections: bacteriology and antibiotic resistance patterns. Indian Pediatr 46: 617-620.
34. Aminzadeh Z, Sadat Kashi M, Sha'bani M (2008) Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis 2: 197-200.
35. Khanfar HS, Bindayna KM, Senok AC, Botta GA (2009) Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 3: 295-299. doi:10.3855/jidc.127.